Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Enteral Nutrition Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Enteral Nutrition Market 26
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Enteral Nutrition Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Enteral Nutrition Market 36
Figure 11. Breakdown of Asia Pacific Enteral Nutrition Market by Nutrient, 2019-2030, % of Revenue 41
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Nutrient, Value ($ mn) and Share (%) 41
Figure 13. Asia Pacific Enteral Nutrition Market: Protein Based Nutrition, 2019-2030, $ mn 42
Figure 14. Asia Pacific Enteral Nutrition Market: Standard Protein Diet, 2019-2030, $ mn 44
Figure 15. Asia Pacific Enteral Nutrition Market: High Protein Supplement, 2019-2030, $ mn 45
Figure 16. Asia Pacific Enteral Nutrition Market: Protein for Diabetic Patients, 2019-2030, $ mn 46
Figure 17. Asia Pacific Enteral Nutrition Market: Other Protein-based Nutitions, 2019-2030, $ mn 47
Figure 18. Asia Pacific Enteral Nutrition Market: Carbohydrates Based Nutrition, 2019-2030, $ mn 48
Figure 19. Asia Pacific Enteral Nutrition Market: Fat Based Nutrition, 2019-2030, $ mn 49
Figure 20. Asia Pacific Enteral Nutrition Market: Vitamin Based Nutrition, 2019-2030, $ mn 50
Figure 21. Asia Pacific Enteral Nutrition Market: Other Nutrition Types, 2019-2030, $ mn 51
Figure 22. Breakdown of Asia Pacific Enteral Nutrition Market by Application, 2019-2030, % of Sales Revenue 53
Figure 23. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 53
Figure 24. Asia Pacific Enteral Nutrition Market: Critical Care, 2019-2030, $ mn 54
Figure 25. Asia Pacific Enteral Nutrition Market: Diabetes, 2019-2030, $ mn 55
Figure 26. Asia Pacific Enteral Nutrition Market: Neurology, 2019-2030, $ mn 56
Figure 27. Asia Pacific Enteral Nutrition Market: Oncology, 2019-2030, $ mn 57
Figure 28. Asia Pacific Enteral Nutrition Market: Other Applications, 2019-2030, $ mn 58
Figure 29. Breakdown of Asia Pacific Enteral Nutrition Market by Category, 2019-2030, % of Sales Revenue 61
Figure 30. Asia Pacific Addressable Market Cap in 2020-2030 by Category, Value ($ mn) and Share (%) 61
Figure 31. Asia Pacific Enteral Nutrition Market: Enteral Nutrition for Chronic Illness, 2019-2030, $ mn 62
Figure 32. Asia Pacific Enteral Nutrition Market: Enteral Nutrition with Standard Formula, 2019-2030, $ mn 63
Figure 33. Breakdown of Asia Pacific Enteral Nutrition Market by Product Form, 2019-2030, % of Revenue 65
Figure 34. Asia Pacific Addressable Market Cap in 2020-2030 by Product Form, Value ($ mn) and Share (%) 65
Figure 35. Asia Pacific Enteral Nutrition Market: Liquid Enteral Nutrition, 2019-2030, $ mn 66
Figure 36. Asia Pacific Enteral Nutrition Market: Powder Enteral Nutrition, 2019-2030, $ mn 67
Figure 37. Breakdown of Asia Pacific Enteral Nutrition Market by End User, 2019-2030, % of Revenue 69
Figure 38. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 69
Figure 39. Asia Pacific Enteral Nutrition Market: Pediatric, 2019-2030, $ mn 70
Figure 40. Asia Pacific Enteral Nutrition Market: Adults, 2019-2030, $ mn 71
Figure 41. Asia Pacific Enteral Nutrition Market: Geriatric, 2019-2030, $ mn 72
Figure 42. Breakdown of Asia Pacific Enteral Nutrition Market by Distribution Channel, 2019-2030, % of Revenue 73
Figure 43. Asia Pacific Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 74
Figure 44. Asia Pacific Enteral Nutrition Market: Distribution by Hospitals, 2019-2030, $ mn 75
Figure 45. Asia Pacific Enteral Nutrition Market: Distribution by Retail Pharmacies, 2019-2030, $ mn 76
Figure 46. Asia Pacific Enteral Nutrition Market: Distribution by Online Pharmacies, 2019-2030, $ mn 77
Figure 47. Breakdown of APAC Enteral Nutrition Market by Country, 2019 and 2030, % of Revenue 79
Figure 48. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 80
Figure 49. Enteral Nutrition Market in Japan, 2019-2030, $ mn 82
Figure 50. Enteral Nutrition Market in China, 2019-2030, $ mn 84
Figure 51. Enteral Nutrition Market in Australia, 2019-2030, $ mn 86
Figure 52. Enteral Nutrition Market in India, 2019-2030, $ mn 89
Figure 53. Enteral Nutrition Market in South Korea, 2019-2030, $ mn 91
Figure 54. Enteral Nutrition Market in Rest of APAC, 2019-2030, $ mn 93
Figure 55. Growth Stage of Asia Pacific Enteral Nutrition Industry over the Forecast Period 95
Asia Pacific enteral nutrition market will grow by 9.7% annually with a total addressable market cap of $46.71 billion over 2020-2030 owing to rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic. Highlighted with 34 tables and 55 figures, this 118-page report “Asia Pacific Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country. Based on Nutrient, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Protein Based Nutrition • Standard Protein Diet • High Protein Supplement • Protein for Diabetic Patients • Other Protein-based Nutitions Carbohydrates Based Nutrition Fat Based Nutrition Vitamin Based Nutrition Other Nutrition Types Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Critical Care • Diabetes • Neurology • Oncology • Other Applications Based on Category, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Enteral Nutrition for Chronic Illness • Enteral Nutrition with Standard Formula Based on Product Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Liquid Enteral Nutrition • Powder Enteral Nutrition Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pediatric • Adults • Geriatric Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Distribution by Hospitals • Distribution by Retail Pharmacies • Distribution by Online Pharmacies Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific enteral nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories B. Braun Melsungen AG Baxter International, Inc. Danone S.A. Fresenius Kabi AG Asia Pacific Health Products, Inc. Hormel Foods Corporation Mead Johnson Nutrition Company Meiji Holdings Co., Ltd. Nestle S.A. Reckitt Benckiser Group LLC Victus, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More